FREMONT, Calif., Jan. 31, 2017 -- MEDABLE Inc. has been recognized as one of the Top 10 Analytics Solution Providers by Pharma Tech Outlook Magazine.
|
|||
“We take pride in honoring MEDABLE as one among the 10 companies that are specialized in providing Analytics solutions for Pharmaceutical Companies,” said Stacey Smith, Managing Editor of Pharma Tech Outlook. “Medable is the most secure platform in healthcare and the only globally compliant cloud solution in healthcare.”
Medable provides the fastest path to a HIPAA compliant healthcare application. Medable's platform provides all the healthcare applications features with the flexibility to support customer’s creative vision.
About MEDABLE
Medable is a privately held company based in Palo Alto. Medable’s products enable healthcare innovation. Medable Cortex is the fastest path to scalable, interoperable, HIPAA compliant applications. Medable Axon is the world's first SmartStudy technology that enables health experts to directly create and launch applications. Medable Cerebrum enables secure analytics across Medable apps on Cortex, Axon or third party backend systems for real-time algorithm-driven patient monitoring and health data visualization. For more info, visit: www.medable.com
About Pharma Tech Outlook
Published from Fremont, California, Pharma Tech Outlook is a print magazine that covers most important and latest developments in pharmaceutical industry. A panel of experts and members of Pharma Tech Outlook’s editorial board selected and finalized the “Top 10 Analytics Solution Providers 2017” and shortlisted the best vendors and consultants. For more info: www.pharmatechoutlook.com
Gary Poole, PR Director [email protected]


Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Instagram Outage Disrupts Thousands of U.S. Users
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Nvidia Nears $20 Billion OpenAI Investment as AI Funding Race Intensifies
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
Anthropic Eyes $350 Billion Valuation as AI Funding and Share Sale Accelerate
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Ford and Geely Explore Strategic Manufacturing Partnership in Europe
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Australian Scandium Project Backed by Richard Friedland Poised to Support U.S. Critical Minerals Stockpile
Nintendo Shares Slide After Earnings Miss Raises Switch 2 Margin Concerns
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised 



